The impact of pharmacotherapy policy: A case study

Canadian Journal of Clinical Pharmacology

Volumn 8, Issue SUPPL. A, 2001, Pages

  Tamblyn, R ^a  

^a ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

Drug costs; Drug use; Insurance; Pharmacotherapy

Indexed keywords

ANALGESIC AGENT; ANTIASTHMATIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTITUSSIVE AGENT; CARDIAC AGENT; DIGOXIN; DRUG; INSULIN; NEUROLEPTIC AGENT; STEROID;

AGED; CANADA; CONFERENCE PAPER; DRUG COST; DRUG INDUCED DISEASE; DRUG USE; HEALTH CARE POLICY; HUMAN; INSURANCE; PHARMACEUTICAL CARE; PRESCRIPTION;

EID: 0035168429     PISSN: 1198581X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (31)

1. Drug plan could drive costs up - Experts: Changes create financial barrier
2. The use of prescription charges
3. Economic impact of cost-containment strategies in third party programmes in the US (Part 1)
4. The effect of patient charges on the utilization of prescription medicines
5. A critical analysis of studies of state drug reimbursement policies: Research in need of discipline
6. The effects of copayments and generic substitution on the use and costs of prescription drugs
7. The effects of co-payments within drug reimbursement programs
8. The demand for prescription drugs as a function of cost-sharing
9. The differential impact of copayment on drug use in a Medicaid population
10. Payment restrictions for prescription drugs under Medicaid: Effects on therapy, cost, and equity
11. The effect of drug co-payments on utilization and cost of pharmaceuticals in a health maintenance organization
12. Charging for health care: Evidence on the utilisation of NHS prescribed drugs
13. The impact of implementing a more restrictive prescription limit on Medicaid recipients
14. The effect of increased prescription drug cost-sharing on medical care utilization and expenses of elderly health maintenance organization members
15. The effect of a Medicaid drug copayment program on the utilization and cost of prescription services
16. Effects of Medicaid drug-payment limits on admission to hospitals and nursing homes
17. Effects of limiting Medicaid drug-reimbursement benefits on the use of psychotropic agents and acute mental health services by patients with schizophrenia
18. Adverse events associated with prescription drug cost-sharing among poor and elderly persons
19. Factors associated with medication noncompliance in rural elderly hypertensive patients
20. Medication compliance in the elderly